MoFo's Braun Advises Astellas in $4B Acquisition


Posted on May 26, 2010 at 9:05 PM

Morrison & Foerster, led by partner Michael Braun, advised Astellas Pharma Inc, which has become Japan's second-largest drugmaker, in an acquisition of Melville, NY-based biotech OSI Pharmaceuticals, Inc. for $57.50 a share in cash, or roughly $4 billion. OSI was advised by a group of lawyers at Skadden, Arps, Slate...

Read More

Blog Search

Get In Touch

Find out if we can help you.  Email us at or call us at +1-917-355-3119